{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:38:57Z","timestamp":1787495937340,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"vor","delay-in-days":58,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008484","name":"BioMarin Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Reports"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.toxrep.2023.02.014","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T18:08:17Z","timestamp":1677694097000},"page":"357-366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Safety, pharmacokinetics and CNS distribution of tralesinidase alfa administered via intracerebroventricular infusion to juvenile cynomolgus monkeys"],"prefix":"10.1016","volume":"10","author":[{"given":"Jason","family":"Pinkstaff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"McCullagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Grover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Melton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Cherukuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill CM","family":"Wait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Butt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jami L.","family":"Trombley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall P.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric.L.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundeep","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Henshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Zanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kovalchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxrep.2023.02.014_bib1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.omtm.2017.05.009","article-title":"Clearance of Heparan Sulfate and Attenuation of CNS Pathology by Intracerebroventricular BMN 250 in Sanfilippo Type B Mice","volume":"6","author":"Aoyagi-Scharber","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.toxrep.2023.02.014_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/pr.2011.13","article-title":"Intrathecal recombinant human 4-sulfatase reduces accumulation of glycosaminoglycans in dura of mucopolysaccharidosis VI cats","volume":"71","author":"Auclair","year":"2012","journal-title":"Pedia Res"},{"key":"10.1016\/j.toxrep.2023.02.014_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004792","article-title":"A plant-derived recombinant human glucocerebrosidase enzyme--a preclinical and phase I investigation","volume":"4","author":"Aviezer","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.toxrep.2023.02.014_bib4","series-title":"Developmental and Reproductive Toxicology: A Practical Approach","article-title":"Nonclinical juvenile toxicity testing","author":"Beck","year":"2012"},{"key":"10.1016\/j.toxrep.2023.02.014_bib5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/0192623310391679","article-title":"Morphologic changes associated with intrathecal catheters for direct delivery to the central nervous system in preclinical studies","volume":"39","author":"Butt","year":"2011","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.toxrep.2023.02.014_bib6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41586-021-03489-0","article-title":"Meningeal lymphatics affect microglia responses and anti-A\u03b2 immunotherapy","volume":"593","author":"Da Mesquita","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.toxrep.2023.02.014_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1124\/jpet.122.001119","article-title":"Tralesinidase Alfa Enzyme Replacement Therapy Prevents Disease Manifestations in a Canine Model of Mucopolysaccharidosis Type IIIB","volume":"382","author":"Ellinwood","year":"2022","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.toxrep.2023.02.014_bib8","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1177\/0192623311409595","article-title":"Safety evaluation of chronic intrathecal administration of idursulfase-IT in cynomolgus monkeys","volume":"39","author":"Felice","year":"2011","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.toxrep.2023.02.014_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nbd.2009.07.028","article-title":"Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases","volume":"37","author":"Gabathuler","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.toxrep.2023.02.014_bib10","first-page":"634","article-title":"Intraventricular vancomycin-induced cerebrospinal fluid eosinophilia: report of two patients","author":"Grabb","year":"1992","journal-title":"Neurosurg. 30, 630-634; Discuss."},{"key":"10.1016\/j.toxrep.2023.02.014_bib11","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s13346-019-00683-6","article-title":"Translational studies of intravenous and intracerebroventricular routes of administration for CNS cellular biodistribution for BMN 250, an enzyme replacement therapy for the treatment of Sanfilippo type B","volume":"10","author":"Grover","year":"2020","journal-title":"Drug Deliv. Transl. Res"},{"key":"10.1016\/j.toxrep.2023.02.014_bib12","unstructured":"ICH-Guidance-S11, 2021, S11 Nonclinical Safety Testing In Support of Development of Pediatric Pharmaceuticals International Council for Harmonisation; Draft Guidance for Industry. \u3008https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/s11-nonclinical-safety-testing-support-development-pediatric-pharmaceuticals\u3009. In Research, C.f.D.E.a.R.C.f.B.E.a., (Ed.), pp."},{"key":"10.1016\/j.toxrep.2023.02.014_bib13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1086\/316953","article-title":"Fabry disease: preclinical studies demonstrate the effectiveness of alpha-galactosidase A replacement in enzyme-deficient mice","volume":"68","author":"Ioannou","year":"2001","journal-title":"Am. J. Hum. Genet"},{"key":"10.1016\/j.toxrep.2023.02.014_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/BJ20130845","article-title":"Insulin-like growth factor II peptide fusion enables uptake and lysosomal delivery of \u03b1-N-acetylglucosaminidase to mucopolysaccharidosis type IIIB fibroblasts","volume":"458","author":"Kan","year":"2014","journal-title":"Biochem J."},{"key":"10.1016\/j.toxrep.2023.02.014_bib15","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1074\/jbc.M112.438663","article-title":"Glycosylation-independent lysosomal targeting of acid \u03b1-glucosidase enhances muscle glycogen clearance in pompe mice","volume":"288","author":"Maga","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxrep.2023.02.014_bib16","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/00006123-198611000-00022","article-title":"Eosinophilia of the cerebrospinal fluid in a case of shunt infection: case report","volume":"19","author":"Mine","year":"1986","journal-title":"Neurosurgery"},{"key":"10.1016\/j.toxrep.2023.02.014_bib17","doi-asserted-by":"crossref","unstructured":"Muschol, N., Koehn, A., von Cossel, K., Okur, I., Ezgu, F., Harmatz, P., de Castro Lopez, M.J., Couce, M.L., Lin, S.P., Batzios, S., Cleary, M., Solano, M., Nestrasil, I., Kaufman, B.D., Shaywitz, A.J., Maricich, S.M., Kuca, B., Kovalchin, J., Zanelli, E.H., 2022, A phase 1\/2 study on intracerebroventricular tralesinidase alfa in patients with Sanfilippo syndrome type B. J Clin Invest.","DOI":"10.1172\/JCI165076"},{"issue":"Pt 3","key":"10.1016\/j.toxrep.2023.02.014_bib18","first-page":"185","article-title":"Developmental and degenerative patterns associated with cognitive, behavioural and motor difficulties in the Sanfilippo syndrome: an epidemiological study","volume":"27","author":"Nidiffer","year":"1983","journal-title":"J. Ment. Defic. Res"},{"key":"10.1016\/j.toxrep.2023.02.014_bib19","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4049\/jimmunol.1900838","article-title":"Meningeal lymphatics: from anatomy to central nervous system immune surveillance","volume":"204","author":"Papadopoulos","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.toxrep.2023.02.014_bib20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1146\/annurev-pathol-051217-111018","article-title":"The glymphatic system in central nervous system health and disease: past, present, and future","volume":"13","author":"Plog","year":"2018","journal-title":"Annu Rev. Pathol."},{"key":"10.1016\/j.toxrep.2023.02.014_bib21","first-page":"41","article-title":"The neurobehavioral phenotype in mucopolysaccharidosis Type IIIB: an exploratory study","volume":"6","author":"Shapiro","year":"2016","journal-title":"Mol. Genet Metab. Rep."},{"key":"10.1016\/j.toxrep.2023.02.014_bib22","doi-asserted-by":"crossref","first-page":"12937","DOI":"10.1073\/pnas.91.26.12937","article-title":"Enzyme replacement in a canine model of Hurler syndrome","volume":"91","author":"Shull","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.toxrep.2023.02.014_bib23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1750-1172-6-43","article-title":"Cognitive development in patients with Mucopolysaccharidosis type III (Sanfilippo syndrome)","volume":"6","author":"Valstar","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.toxrep.2023.02.014_bib24","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ymgme.2011.03.011","article-title":"Biodistribution and pharmacodynamics of recombinant human alpha-L-iduronidase (rhIDU) in mucopolysaccharidosis type I-affected cats following multiple intrathecal administrations","volume":"103","author":"Vite","year":"2011","journal-title":"Mol. Genet Metab."},{"key":"10.1016\/j.toxrep.2023.02.014_bib25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ymgme.2011.06.018","article-title":"Intrathecal tripeptidyl-peptidase 1 reduces lysosomal storage in a canine model of late infantile neuronal ceroid lipofuscinosis","volume":"104","author":"Vuillemenot","year":"2011","journal-title":"Mol. Genet Metab."},{"key":"10.1016\/j.toxrep.2023.02.014_bib26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.taap.2014.03.005","article-title":"Recombinant human tripeptidyl peptidase-1 infusion to the monkey CNS: safety, pharmacokinetics, and distribution","volume":"277","author":"Vuillemenot","year":"2014","journal-title":"Toxicol. Appl. Pharm."},{"key":"10.1016\/j.toxrep.2023.02.014_bib27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1472-6807-3-8","article-title":"A model of tripeptidyl-peptidase I (CLN2), a ubiquitous and highly conserved member of the sedolisin family of serine-carboxyl peptidases","volume":"3","author":"Wlodawer","year":"2003","journal-title":"BMC Struct. Biol."}],"container-title":["Toxicology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750023000288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750023000288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T15:51:22Z","timestamp":1762012282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214750023000288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":27,"alternative-id":["S2214750023000288"],"URL":"https:\/\/doi.org\/10.1016\/j.toxrep.2023.02.014","relation":{},"ISSN":["2214-7500"],"issn-type":[{"value":"2214-7500","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety, pharmacokinetics and CNS distribution of tralesinidase alfa administered via intracerebroventricular infusion to juvenile cynomolgus monkeys","name":"articletitle","label":"Article Title"},{"value":"Toxicology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxrep.2023.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}